Posted on 2/11/20
Sirtex Medical Closes Strategic Transaction with OncoSec Medical
Sirtex Medical US Holdings, Inc., a leading manufacturer of targeted liver cancer therapies, today announced that the shareholders of OncoSec Medical, Inc. have approved, and the . . .
Posted on 2/10/20
Iora Health Closes $126 Million Series F Funding Round
Boston-based Iora Health, an innovative primary care provider network with a mission to restore humanity to healthcare, today announced an investment of $126 Million
Posted on 2/10/20
ReForm Biologics and MilliporeSigma Announce a Licensing Agreement
WOBURN, Mass.--(BUSINESS WIRE)--ReForm Biologics LLC, a pharmaceutical technology company developing innovative platforms to improve biologic formulations and MilliporeSigma today announced a global license agreement and collaboration . . .
Posted on 2/10/20
Cresco Labs Closes Acquisition of Massachusetts Cannabis Grower and Retailer
Another slowly developing acquisition in the cannabis industry has been finalized. Cresco Labs (OTC:CRLBF) announced Friday it has closed its buyout of grower and retailer Hope . . .
Posted on 2/10/20
AGTC Announces Pricing of $32.5M Public Offering of Common Stock
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 06, 2020 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated . . .
Posted on 2/10/20
Corbus Pharmaceuticals Proposes Public Offering of Common Stock
Norwood, MA, Feb. 06, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid . . .
Posted on 2/10/20
Corbus Pharmaceuticals Prices Public Offering of Common Stock
Norwood, MA, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP), a clinical-stage drug development company pioneering transformative medicines that target the endocannabinoid . . .
Posted on 2/7/20
Bristol-Myers Squibb's Earnings Get a Boost From Celgene Acquisition
Fourth-quarter revenue at Bristol-Myers Squibb (NYSE:BMY) jumped 33% year over year thanks to its purchase of Celgene, which closed in the latter half of November. On . . .
Posted on 2/7/20
Cigna's Express Scripts Acquisition Continues to Pay Off With Its Q4 Earnings Beat
Cigna Corporation (NYSE:CI) took investors on a wild ride in 2019. The stock plunged more than 20%, only to make a big comeback toward the end . . .
Posted on 2/7/20
Phio Pharmaceuticals Closes $1.74M Registered Direct Offering Priced At-the-Market
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 2/6/20
Curis and Aurigene Announce Amendment of Collaboration for the Development and Commercialization of CA-170
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into . . .
Posted on 2/6/20
CarePort Partners with Allegheny Health Network
BOSTON--(BUSINESS WIRE)--CarePort Health, a pioneer in post-acute outcomes management, today announced that Pittsburgh-based Allegheny Health Network (AHN), the provider arm of Highmark Health – one of . . .
Posted on 2/6/20
Why Biogen Shares Soared Today
What happenedShares of Biogen (NASDAQ:BIIB) were soaring 17.2% as of 2:59 p.m. EST on Wednesday after rising as much as 32.4% earlier in the afternoon. The . . .
Posted on 2/6/20
Biogen Surges After Winning Crucial Multiple Sclerosis Drug Patent
Biogen (NASDAQ:BIIB) is up 18% today as news regarding a crucial patent ruling came out in the company's favor. A U.S. appeals panels denied a patient . . .
Posted on 2/6/20
Beam Therapeutics Prices IPO
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the pricing of its initial public offering . . .
Posted on 2/6/20
Phio Pharmaceuticals Announces $1.74 Million Registered Direct Offering
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-oncology therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic platform, today announced . . .
Posted on 2/5/20
Foley Hoag Represents Biogen in $1 Billion Credit Facility
Foley Hoag LLP advised Biogen Inc. (Nasdaq: BIIB), a global biotechnology company, in connection with its $1.0 billion senior unsecured revolving credit facility.Biogen entered the credit . . .
Posted on 2/5/20
ALK-Abelló and X-Chem Announce Drug Discovery Collaboration
WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem, Inc. (X-Chem), a privately held biotechnology company focused on applying its next-generation, industry-leading DNA-Encoded library drug discovery platform to the generation of novel . . .
Posted on 2/5/20
Bristol-Myers: Buy At The Highs
SummaryBristol-Myers closed the Celgene acquisition back in November proving an immediate 40% accretion to BMY earnings.Investors should watch for 2020 guidance to top $6.20 EPS estimates . . .
Posted on 2/5/20
Bristol-Myers Squibb and BioMotiv Launch Fibrosis Specialist Anteros Pharmaceuticals
Bristol-Myers Squibb (NYSE:BMY) and drug development accelerator BioMotiv have launched Anteros Pharmaceuticals, a biotech company focused on developing drugs for fibrotic and other inflammatory diseases. The . . .
Posted on 2/4/20
Vynamic Expands to Meet Growing Demand with 4th Office
Vynamic, a leading global healthcare industry management consulting firm, has announced the opening of its fourth office in Durham, North Carolina.With offices in Philadelphia (HQ), Boston, . . .
Posted on 2/4/20
Trianni and Mablytics Announce License Agreement for the Trianni Mouse
Trianni, Inc. and Mablytics, Inc. jointly announced today that they have entered into a license agreement for the use of the Trianni Mouse®, a transgenic mouse R&D . . .
Posted on 2/4/20
CVS Health: Its Economic Moat Is Underestimated
SummaryCVS has significant cost-savings ahead from its recent acquisition of Aetna and planned modernization.CVS vertical integration has increased the company's presence throughout the retail supply chain.The . . .
Posted on 2/4/20
InVivo Therapeutics Announces Reverse Stock Split
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced a 1-for-30 reverse stock split of its common stock and a proportionate reduction in its authorized . . .
Posted on 2/3/20
CVS Health Announces Upcoming Changes to Board of Directors
CVS Health (NYSE: CVS) today announced upcoming changes to its Board of Directors. Richard "Dick" Swift, Richard Bracken and Mark Bertolini will not stand for reelection . . .

